Busca un médico

David Toro Tobon, M.D.

  1. Endocrinologist

Publicaciones

  1. Brito JP, Herrin J, Swarna KS, Singh Ospina NM, Montori VM, Toro-Tobon D, Umpierrez GE, Galindo RJ, Deng Y, Mickelson MM, Shao H, Polley EC, McCoy RG. GLP-1RA Use and Thyroid Cancer Risk. JAMA Otolaryngol Head Neck Surg. 2025 Mar 1; 151 (3):243-252
    View PubMed
  2. Gorris MA, Randle RW, Obermiller CS, Thomas J, Toro-Tobon D, Dream SY, Fackelmayer OJ, Pandian TK, Mayson SE. Assessing ChatGPT's Capability in Addressing Thyroid Cancer Patient Queries: A Comprehensive Mixed-Methods Evaluation. J Endocr Soc. 2025 Jan 6; 9 (2):bvaf003 Epub 2025 Jan 13
    View PubMed
  3. Toro-Tobon D, Singh Ospina N, Brito JP. Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Thyroid. 2025 Jan; 35 (1):3-5 Epub 2025 Jan 08
    View PubMed
  4. El Kawkgi O, Toro-Tobon D, Toloza FJK, Vallejo S, Jacome CS, Ayala IN, Vallejo BA, Wenczenovicz C, Tzeng O, Spencer HJ, Thostenson JD, Li D, Kohlenberg J, Lincango E, Mohan S, Castellanos-Diaz J, Maraka S, Ospina NS, Brito JP. A Predictive Model for Graves' Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study. Endocr Pract. 2024 Dec 16 [Epub ahead of print]
    View PubMed
  5. Toro-Tobon D, Brito JP. Controversies in the Management of Intermediate-Risk Differentiated Thyroid Cancer. Endocr Pract. 2024 Sep; 30 (9):879-886 Epub 2024 June 12
    View PubMed
  6. Loor-Torres R, Duran M, Toro-Tobon D, Chavez MM, Ponce O, Jacome CS, Torres DS, Perneth SA, Montori V, Golembiewski E, Osorio MB, Fan JW, Ospina NS, Wu Y, Brito JP. A Systematic Review of Natural Language Processing Methods and Applications in Thyroidology. Mayo Clin Proc Digit Health. 2024 Jun; 2 (2):270-279 Epub 2024 May 21
    View PubMed
  7. Welch AA, Toro-Tobon D, Rachmasari KN, Sandooja RB, Rahimi L, Mohan S, Hewlett JR, Clark J, Maheshwari A, Zhang C, Brito JP. Improving Intravenous and Subcutaneous Insulin Overlap During Treatment of Diabetic Ketoacidosis: A Quality Improvement Project. Mayo Clin Proc Innov Qual Outcomes. 2024 Jun; 8 (3):293-300 Epub 2024 May 22
    View PubMed
  8. Jacome CS, Torres DS, Fan JW, Loor-Torres R, Duran M, Zahidy MA, Cabezas E, Borras-Osorio M, Toro-Tobon D, Wu Y, Wu Y, Ospina NS, Brito JP. Thyroid Ultrasound Appropriateness Identification Through Natural Language Processing of Electronic Health Records. Mayo Clin Proc Digit Health. 2024 Mar; 2 (1):67-74 Epub 2024 Feb 01
    View PubMed
  9. Hidalgo J, Vallejo BA, Soto Jacome C, Ayala IN, Cordova S, Duran M, Golembiewski E, Toro-Tobon D, Brito JP. Real Practice Assessment of Persistent Symptoms After Initiation of Levothyroxine. Endocr Pract. 2024 Feb; 30 (2):95-100 Epub 2023 Oct 31
    View PubMed
  10. Ayala IN, Soto Jacome C, Toro-Tobon D, Golembiewski E, Garcia-Bautista A, Hidalgo J, Cordova-Madera S, Al Anbari R, Sohn R J, Singh Ospina N, Maraka S, Joseph M, Brito JP. Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study. J Clin Endocrinol Metab. 2024 Jan 18; 109 (2):e765-e772
    View PubMed
  11. Jacome CS, Garcia A, Golembiewski E, Loor-Torres R, Duran M, Segura D, Toro-Tobon D, Fan JW, Singh Ospina N, Brito JP. Physical Examination of the Thyroid: Accuracy in Detecting Thyroid Nodules and Frequency of Additional Findings. Endocr Pract. 2024 Jan; 30 (1):31-35 Epub 2023 Oct 05
    View PubMed
  12. Toro-Tobon D, Morris JC, Hilger C, Peskey C, Durski JM, Ryder M. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers. Thyroid. 2024 Jan; 34(1):70-81. Epub 2023 Dec 12.
    View PubMed
  13. Soto Jacome C, Segura Torres D, Fan JW, Garcia-Bautista A, Golembiewski E, Duran M, Loor-Torres R, Toro-Tobon D, Singh Ospina N, Brito JP. Drivers of Thyroid Ultrasound Use: A Retrospective Observational Study. Endocr Pract. 2023 Dec; 29 (12):948-954 Epub 2023 Sept 16
    View PubMed
  14. Toro-Tobon D, Rachmasari KN, Bradley EA, Wagner LH, Tooley AA, Stokken JK, Stan MN. Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye Disease. Thyroid. 2023 Oct; 33 (10):1237-1244 Epub 2023 Aug 23
    View PubMed
  15. Toro-Tobon D, Loor-Torres R, Duran M, Fan JW, Singh Ospina N, Wu Y, Brito JP. Artificial Intelligence in Thyroidology: A Narrative Review of the Current Applications, Associated Challenges, and Future Directions. Thyroid. 2023 Aug; 33 (8):903-917 Epub 2023 June 26
    View PubMed
  16. Kittithaworn A, Toro-Tobon D, Sfeir JG. Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility. Womens Health (Lond). 2023 Jan-Dec; 19:17455057231170059
    View PubMed
  17. Toro-Tobon D, Thornton S. Awareness, perceptions, and characteristics of internal medicine residents as role models. Clin Teach. 2022 Dec; 19 (6):e13526 Epub 2022 Sept 05
    View PubMed
  18. Kristan MM, Toro-Tobon D, Francis N, Desale S, Bikas A, Jonklaas J, Goyal RM. Immunotherapy-Associated Hypothyroidism: Comparison of the Pre-Existing With De-Novo Hypothyroidism. Front Endocrinol (Lausanne). 2022; 13:798253 Epub 2022 Mar 11
    View PubMed
  19. Montero AR, Toro-Tobon D, Gann K, Nassar CM, Youssef GA, Magee MF. Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care. BMC Endocr Disord. 2021 Nov 10; 21 (1):222
    View PubMed
  20. Chivukula KK, Toro-Tobon D, Motazedi B, Goyal R. Thyroid storm as an early presentation of hCG-producing metastatic choriocarcinoma: a case report and review of the literature. BMJ Case Rep. 2021 Sep 27; 14 (9) Epub 2021 Sept 27
    View PubMed
  21. Toro-Tobón D, Berbesi-Fernández D. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling. Subst Use Misuse. 2020; 55(3):414-423. Epub 2019 Nov 06.
    View PubMed
  22. Toro-Tobón D, Berbesi-Fernández D, Trejos-Castillo E, Arbelaez SG. Gender Differences in Risky Injection Practices Among People Who Inject Drugs in Colombia Addictive Disorders & Their Treatment. 2019; 18(3):140.
  23. Toro-Tobón D, Toro-Tobon D, Berbesi-Fernandez D, Mateu-Gelabert P, Segura-Cardona AM, Montoya-Velez LP. Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using Respondent Driven Sampling. Int J Drug Policy. 2018 Oct; 60:56-64 Epub 2018 Aug 11
    View PubMed
  24. Mateu-Gelabert P, Guarino H, Quinn K, Meylakhs P, Campos S, Meylakhs A, Berbesi D, Toro-Tobon D, Toro-Tobón D, Goodbody E, Ompad DC, Friedman SR. Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention. Curr HIV/AIDS Rep. 2018 Aug; 15 (4):324-335
    View PubMed
  25. Toro-Tobón D, Toro-Tobon D, Agosto S, Ahmadi S, Koops M, Bruder JM. Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review. Am J Case Rep. 2017 Feb 27; 18:203-207
    View PubMed
  26. Toro-Tobon D, Berbesi-Fernandez D, Mateu-Gelabert P, Segura-Cardona AM, Montoya-Velez LP. Drug dealing and drug using behaviors among people who inject drugs in Colombia: A cross-sectional study. J Subst Use. 2017; 22 (6):630-636 Epub 2017 Mar 28
    View PubMed
  27. Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Toro-Tobon D, Stan MN. Graves’ Disease and the Manifestations of Thyrotoxicosis South Dartmouth (MA): MDText.com, Inc.. 2000.
    View PubMed
PST-20575676